Private joint-stock company Darnitsa pharmaceutical firm (Kyiv) saw a 48.9% fall in net profit in January-June YoY, to 144.29 million UAH.
Its net revenue grew by 19.6%, to 976.3 million UAH and gross profit grew by 3.23%, to 534.75 million UAH.
In Q1 2016 the firm saw a 59.4% fall in net profit YoY, to 89.33 million UAH.
In July-September 2015 the firm saw a 42.4% rise in net profit YoY, to 282.53 million UAH. In 2014 the company saw a 47.8% rise in net profit, totaling 295.95 million UAH.
Darnitsa pharmaceutical firm is among the top-ten largest pharmaceutical producers of Ukraine and is one of the top-ten largest suppliers to hospitals. (Interfax/Business World Magazine)